Works matching DE "TAZOBACTAM"
Results: 507
Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 2, p. 372, doi. 10.1093/jac/dkae413
- By:
- Publication type:
- Article
Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum.
- Published in:
- Journal of Applied Laboratory Medicine, 2021, v. 6, n. 5, p. 1202, doi. 10.1093/jalm/jfab036
- By:
- Publication type:
- Article
Fever and reversible laboratory abnormalities associated with prolonged use of piperacillin/tazobactam: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2024, p. 1, doi. 10.1177/2050313X241285675
- By:
- Publication type:
- Article
Therapeutic Management of Preputial Prolapse in Gir Bulls.
- Published in:
- Indian Journal of Animal Reproduction, 2021, v. 42, n. 2, p. 22, doi. 10.48165/ijar.2021.42.2.4
- By:
- Publication type:
- Article
Incidence and Risk Factors for Acute Kidney Injury in Hospitalized Children Receiving Piperacillin-Tazobactam.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 6, p. 597, doi. 10.5863/1551-6776-26.6.597
- By:
- Publication type:
- Article
Incidence of Acute Kidney Injury Among Infants in the Neonatal Intensive Care Unit Receiving Vancomycin With Either Piperacillin/Tazobactam or Cefepime.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 6, p. 521, doi. 10.5863/1551-6776-25.6.521
- By:
- Publication type:
- Article
Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 9, p. 1787, doi. 10.1007/s10096-024-04896-7
- By:
- Publication type:
- Article
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 9, p. 1861, doi. 10.1007/s10096-024-04879-8
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy—SMART 2017–2021.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2024, v. 43, n. 7, p. 1343, doi. 10.1007/s10096-024-04756-4
- By:
- Publication type:
- Article
In vitro and in vivo evaluation of two combined β-lactamase inhibitors against carbapenem-resistant Acinetobacter baumannii.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 11, p. 1317, doi. 10.1007/s10096-023-04664-z
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 3, p. 365, doi. 10.1007/s10096-023-04549-1
- By:
- Publication type:
- Article
Effect of restricting piperacillin/tazobactam prescription on rates of antimicrobial resistance in gram-negative bacteria and antibiotic consumption.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2023, v. 42, n. 1, p. 53, doi. 10.1007/s10096-022-04525-1
- By:
- Publication type:
- Article
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 12, p. 2533, doi. 10.1007/s10096-021-04308-0
- By:
- Publication type:
- Article
Ceftolozane/tazobactam for Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis adult patients: a case series.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 10, p. 2211, doi. 10.1007/s10096-021-04218-1
- By:
- Publication type:
- Article
Continuous infusion of ceftolozane/tazobactam is associated with a higher probability of target attainment in patients infected with Pseudomonas aeruginosa.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 8, p. 1457, doi. 10.1007/s10096-019-03573-4
- By:
- Publication type:
- Article
O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection of high-risk clones.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 3, p. 541, doi. 10.1007/s10096-018-03457-z
- By:
- Publication type:
- Article
A comparison of Sensititre™ Anaerobe MIC plate with ATB ANA® test for the routine susceptibility testing of common anaerobe pathogens.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 12, p. 2279, doi. 10.1007/s10096-018-3369-5
- By:
- Publication type:
- Article
Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 11, p. 2191, doi. 10.1007/s10096-018-3361-0
- By:
- Publication type:
- Article
Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2018, v. 37, n. 8, p. 1411, doi. 10.1007/s10096-018-3260-4
- By:
- Publication type:
- Article
Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2017, v. 36, n. 3, p. 459, doi. 10.1007/s10096-016-2819-1
- By:
- Publication type:
- Article
Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 7, p. 1437, doi. 10.1007/s10096-015-2370-5
- By:
- Publication type:
- Article
New promising β-lactamase inhibitors for clinical use.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 7, p. 1303, doi. 10.1007/s10096-015-2375-0
- By:
- Publication type:
- Article
International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2013, v. 32, n. 8, p. 997, doi. 10.1007/s10096-013-1837-5
- By:
- Publication type:
- Article
Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2011, v. 30, n. 10, p. 1185, doi. 10.1007/s10096-011-1210-5
- By:
- Publication type:
- Article
Activity of doripenem against extended-spectrum β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.
- Published in:
- 2010
- By:
- Publication type:
- Report
The association between antibiotic use and resistance: the role of secondary antibiotics.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2010, v. 29, n. 9, p. 1125, doi. 10.1007/s10096-010-0972-5
- By:
- Publication type:
- Article
Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2007, v. 26, n. 3, p. 213, doi. 10.1007/s10096-007-0256-x
- By:
- Publication type:
- Article
Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2007, v. 26, n. 3, p. 189, doi. 10.1007/s10096-007-0263-y
- By:
- Publication type:
- Article
Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 3, p. 1227, doi. 10.1007/s40121-021-00491-x
- By:
- Publication type:
- Article
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 2, p. 939, doi. 10.1007/s40121-021-00436-4
- By:
- Publication type:
- Article
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 953, doi. 10.1007/s40121-020-00343-0
- By:
- Publication type:
- Article
Time-Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients.
- Published in:
- Infectious Diseases & Therapy, 2017, v. 6, n. 4, p. 507, doi. 10.1007/s40121-017-0176-8
- By:
- Publication type:
- Article
PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease.
- Published in:
- 2017
- By:
- Publication type:
- Report
Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.
- Published in:
- Infectious Diseases & Therapy, 2016, v. 5, n. 3, p. 367, doi. 10.1007/s40121-016-0121-2
- By:
- Publication type:
- Article
Fecal Carriage and Genetic Characterization of CTX-M-1/9/1-Producing Escherichia coli From Healthy Humans in Hangzhou, China.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.616687
- By:
- Publication type:
- Article
In vitro detection of Candida and Aspergillus antigen in parenteral nutrition and fixed combinations of piperacillin‐tazobactam.
- Published in:
- Mycoses, 2018, v. 61, n. 12, p. 931, doi. 10.1111/myc.12841
- By:
- Publication type:
- Article
In Vitro Activity of Ceftolozane/Tazobactam against Clinical Pseudomonas aeruginosa Isolates Collected in South Korea - SMART 2017-2018.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, p. S279
- By:
- Publication type:
- Article
In Vitro Activity of Ceftolozane/Tazobactam against Clinical Enterobacterales Isolates Collected in South Korea - SMART 2017-2018.
- Published in:
- Infection & Chemotherapy, 2020, v. 52, p. S277
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Piperacillin/Tazobactam in Korean Patients with Acute Infections.
- Published in:
- Infection & Chemotherapy, 2016, v. 48, n. 3, p. 209, doi. 10.3947/ic.2016.48.3.209
- By:
- Publication type:
- Article
Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens.
- Published in:
- Infection & Chemotherapy, 2014, v. 46, n. 3, p. 149, doi. 10.3947/ic.2014.46.3.149
- By:
- Publication type:
- Article
Understanding the binding conformation of ceftolozane/tazobactam with Metallo‐β‐lactamases VIM‐5 and IMP‐7 of Pseudomonas aeruginosa: A molecular docking and virtual screening process.
- Published in:
- Journal of Molecular Recognition, 2021, v. 34, n. 9, p. 1, doi. 10.1002/jmr.2898
- By:
- Publication type:
- Article
Simultaneous determination of clavulanic acid and tazobactam in bovine milk by HPLC.
- Published in:
- Food Additives & Contaminants. Part A: Chemistry, Analysis, Control, Exposure & Risk Assessment, 2017, v. 34, n. 4, p. 617, doi. 10.1080/19440049.2016.1277271
- By:
- Publication type:
- Article
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2334-14-29
- By:
- Publication type:
- Article
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
- Published in:
- BMC Infectious Diseases, 2010, v. 10, n. 1, p. 72, doi. 10.1186/1471-2334-10-72
- By:
- Publication type:
- Article
Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: A retrospective study.
- Published in:
- BMC Infectious Diseases, 2008, v. 8, n. 1, p. 1, doi. 10.1186/1471-2334-8-67
- By:
- Publication type:
- Article
Ceftolozane sulfate with tazobactam sodium.
- Published in:
- Australian Prescriber, 2016, v. 39, n. 3, p. 106, doi. 10.18773/austprescr.2016.044
- Publication type:
- Article
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 8, p. 2287, doi. 10.1007/s00520-014-2582-8
- By:
- Publication type:
- Article
Synthesis and biological activity of alkylidene-substituted cephems and penams.
- Published in:
- Chemistry of Heterocyclic Compounds, 2011, v. 47, n. 6, p. 767, doi. 10.1007/s10593-011-0832-y
- By:
- Publication type:
- Article